nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Trauma—Bleomycin—melanoma	0.0459	0.0459	CcSEcCtD
Nalidixic Acid—Intracranial pressure increased—Carmustine—melanoma	0.0456	0.0456	CcSEcCtD
Nalidixic Acid—Cholestasis—Temozolomide—melanoma	0.0243	0.0243	CcSEcCtD
Nalidixic Acid—Eosinophilia—Vemurafenib—melanoma	0.0224	0.0224	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Vemurafenib—melanoma	0.0206	0.0206	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.02	0.02	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Vemurafenib—melanoma	0.0198	0.0198	CcSEcCtD
Nalidixic Acid—Injury—Bleomycin—melanoma	0.0172	0.0172	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Vemurafenib—melanoma	0.0171	0.0171	CcSEcCtD
Nalidixic Acid—Erythema—Vemurafenib—melanoma	0.0158	0.0158	CcSEcCtD
Nalidixic Acid—Swelling—Carmustine—melanoma	0.0157	0.0157	CcSEcCtD
Nalidixic Acid—Injury—Carmustine—melanoma	0.0151	0.0151	CcSEcCtD
Nalidixic Acid—Diplopia—Carmustine—melanoma	0.0138	0.0138	CcSEcCtD
Nalidixic Acid—Arthralgia—Vemurafenib—melanoma	0.0134	0.0134	CcSEcCtD
Nalidixic Acid—Diplopia—Temozolomide—melanoma	0.0134	0.0134	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Vemurafenib—melanoma	0.0129	0.0129	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Vemurafenib—melanoma	0.0117	0.0117	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.0113	0.0113	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Temozolomide—melanoma	0.0105	0.0105	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Carmustine—melanoma	0.0105	0.0105	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Temozolomide—melanoma	0.0102	0.0102	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Temozolomide—melanoma	0.0101	0.0101	CcSEcCtD
Nalidixic Acid—Swelling—Docetaxel—melanoma	0.0101	0.0101	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Dactinomycin—melanoma	0.00967	0.00967	CcSEcCtD
Nalidixic Acid—Erythema—Bleomycin—melanoma	0.00955	0.00955	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Docetaxel—melanoma	0.0093	0.0093	CcSEcCtD
Nalidixic Acid—Asthenia—Vemurafenib—melanoma	0.00923	0.00923	CcSEcCtD
Nalidixic Acid—Visual impairment—Carmustine—melanoma	0.00922	0.00922	CcSEcCtD
Nalidixic Acid—Pruritus—Vemurafenib—melanoma	0.0091	0.0091	CcSEcCtD
Nalidixic Acid—Visual impairment—Temozolomide—melanoma	0.00891	0.00891	CcSEcCtD
Nalidixic Acid—Erythema—Dactinomycin—melanoma	0.0089	0.0089	CcSEcCtD
Nalidixic Acid—Diarrhoea—Vemurafenib—melanoma	0.0088	0.0088	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Temozolomide—melanoma	0.00875	0.00875	CcSEcCtD
Nalidixic Acid—Leukopenia—Bleomycin—melanoma	0.00854	0.00854	CcSEcCtD
Nalidixic Acid—Dizziness—Vemurafenib—melanoma	0.0085	0.0085	CcSEcCtD
Nalidixic Acid—Erythema—Carmustine—melanoma	0.00833	0.00833	CcSEcCtD
Nalidixic Acid—Vomiting—Vemurafenib—melanoma	0.00818	0.00818	CcSEcCtD
Nalidixic Acid—Rash—Vemurafenib—melanoma	0.00811	0.00811	CcSEcCtD
Nalidixic Acid—Dermatitis—Vemurafenib—melanoma	0.0081	0.0081	CcSEcCtD
Nalidixic Acid—Headache—Vemurafenib—melanoma	0.00806	0.00806	CcSEcCtD
Nalidixic Acid—Erythema—Temozolomide—melanoma	0.00805	0.00805	CcSEcCtD
Nalidixic Acid—Leukopenia—Dactinomycin—melanoma	0.00797	0.00797	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Bleomycin—melanoma	0.00779	0.00779	CcSEcCtD
Nalidixic Acid—Nausea—Vemurafenib—melanoma	0.00764	0.00764	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Bleomycin—melanoma	0.00763	0.00763	CcSEcCtD
Nalidixic Acid—Leukopenia—Carmustine—melanoma	0.00746	0.00746	CcSEcCtD
Nalidixic Acid—Angioedema—Temozolomide—melanoma	0.00736	0.00736	CcSEcCtD
Nalidixic Acid—Vertigo—Temozolomide—melanoma	0.00723	0.00723	CcSEcCtD
Nalidixic Acid—Convulsion—Carmustine—melanoma	0.00722	0.00722	CcSEcCtD
Nalidixic Acid—Leukopenia—Temozolomide—melanoma	0.00721	0.00721	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Dactinomycin—melanoma	0.00711	0.00711	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Bleomycin—melanoma	0.0071	0.0071	CcSEcCtD
Nalidixic Acid—Paraesthesia—Bleomycin—melanoma	0.007	0.007	CcSEcCtD
Nalidixic Acid—Convulsion—Temozolomide—melanoma	0.00698	0.00698	CcSEcCtD
Nalidixic Acid—Arthralgia—Temozolomide—melanoma	0.00685	0.00685	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00679	0.00679	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Docetaxel—melanoma	0.00672	0.00672	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Carmustine—melanoma	0.00666	0.00666	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00662	0.00662	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Temozolomide—melanoma	0.00657	0.00657	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Temozolomide—melanoma	0.00643	0.00643	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Carmustine—melanoma	0.0062	0.0062	CcSEcCtD
Nalidixic Acid—Urticaria—Bleomycin—melanoma	0.00619	0.00619	CcSEcCtD
Nalidixic Acid—Paraesthesia—Carmustine—melanoma	0.00611	0.00611	CcSEcCtD
Nalidixic Acid—Somnolence—Carmustine—melanoma	0.00605	0.00605	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Temozolomide—melanoma	0.00599	0.00599	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Dactinomycin—melanoma	0.00594	0.00594	CcSEcCtD
Nalidixic Acid—Visual impairment—Docetaxel—melanoma	0.00593	0.00593	CcSEcCtD
Nalidixic Acid—Paraesthesia—Temozolomide—melanoma	0.0059	0.0059	CcSEcCtD
Nalidixic Acid—Somnolence—Temozolomide—melanoma	0.00584	0.00584	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Docetaxel—melanoma	0.00582	0.00582	CcSEcCtD
Nalidixic Acid—Abdominal pain—Dactinomycin—melanoma	0.00574	0.00574	CcSEcCtD
Nalidixic Acid—Asthenia—Bleomycin—melanoma	0.00559	0.00559	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Carmustine—melanoma	0.00556	0.00556	CcSEcCtD
Nalidixic Acid—Pruritus—Bleomycin—melanoma	0.00551	0.00551	CcSEcCtD
Nalidixic Acid—Abdominal pain—Carmustine—melanoma	0.00538	0.00538	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Temozolomide—melanoma	0.00537	0.00537	CcSEcCtD
Nalidixic Acid—Erythema—Docetaxel—melanoma	0.00535	0.00535	CcSEcCtD
Nalidixic Acid—Urticaria—Temozolomide—melanoma	0.00522	0.00522	CcSEcCtD
Nalidixic Acid—Asthenia—Dactinomycin—melanoma	0.00521	0.00521	CcSEcCtD
Nalidixic Acid—Abdominal pain—Temozolomide—melanoma	0.00519	0.00519	CcSEcCtD
Nalidixic Acid—Diarrhoea—Dactinomycin—melanoma	0.00497	0.00497	CcSEcCtD
Nalidixic Acid—Vomiting—Bleomycin—melanoma	0.00495	0.00495	CcSEcCtD
Nalidixic Acid—Rash—Bleomycin—melanoma	0.00491	0.00491	CcSEcCtD
Nalidixic Acid—Dermatitis—Bleomycin—melanoma	0.00491	0.00491	CcSEcCtD
Nalidixic Acid—Asthenia—Carmustine—melanoma	0.00488	0.00488	CcSEcCtD
Nalidixic Acid—Leukopenia—Docetaxel—melanoma	0.00479	0.00479	CcSEcCtD
Nalidixic Acid—Asthenia—Temozolomide—melanoma	0.00471	0.00471	CcSEcCtD
Nalidixic Acid—Diarrhoea—Carmustine—melanoma	0.00465	0.00465	CcSEcCtD
Nalidixic Acid—Pruritus—Temozolomide—melanoma	0.00465	0.00465	CcSEcCtD
Nalidixic Acid—Convulsion—Docetaxel—melanoma	0.00464	0.00464	CcSEcCtD
Nalidixic Acid—Nausea—Bleomycin—melanoma	0.00463	0.00463	CcSEcCtD
Nalidixic Acid—Vomiting—Dactinomycin—melanoma	0.00462	0.00462	CcSEcCtD
Nalidixic Acid—Rash—Dactinomycin—melanoma	0.00458	0.00458	CcSEcCtD
Nalidixic Acid—Arthralgia—Docetaxel—melanoma	0.00456	0.00456	CcSEcCtD
Nalidixic Acid—Dizziness—Carmustine—melanoma	0.0045	0.0045	CcSEcCtD
Nalidixic Acid—Diarrhoea—Temozolomide—melanoma	0.0045	0.0045	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Docetaxel—melanoma	0.00437	0.00437	CcSEcCtD
Nalidixic Acid—Dizziness—Temozolomide—melanoma	0.00435	0.00435	CcSEcCtD
Nalidixic Acid—Vomiting—Carmustine—melanoma	0.00432	0.00432	CcSEcCtD
Nalidixic Acid—Nausea—Dactinomycin—melanoma	0.00432	0.00432	CcSEcCtD
Nalidixic Acid—Rash—Carmustine—melanoma	0.00429	0.00429	CcSEcCtD
Nalidixic Acid—Dermatitis—Carmustine—melanoma	0.00428	0.00428	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Docetaxel—melanoma	0.00428	0.00428	CcSEcCtD
Nalidixic Acid—Headache—Carmustine—melanoma	0.00426	0.00426	CcSEcCtD
Nalidixic Acid—Vomiting—Temozolomide—melanoma	0.00418	0.00418	CcSEcCtD
Nalidixic Acid—Rash—Temozolomide—melanoma	0.00414	0.00414	CcSEcCtD
Nalidixic Acid—Dermatitis—Temozolomide—melanoma	0.00414	0.00414	CcSEcCtD
Nalidixic Acid—Headache—Temozolomide—melanoma	0.00412	0.00412	CcSEcCtD
Nalidixic Acid—Nausea—Carmustine—melanoma	0.00404	0.00404	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Docetaxel—melanoma	0.00398	0.00398	CcSEcCtD
Nalidixic Acid—Paraesthesia—Docetaxel—melanoma	0.00392	0.00392	CcSEcCtD
Nalidixic Acid—Nausea—Temozolomide—melanoma	0.0039	0.0039	CcSEcCtD
Nalidixic Acid—Somnolence—Docetaxel—melanoma	0.00388	0.00388	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Docetaxel—melanoma	0.00357	0.00357	CcSEcCtD
Nalidixic Acid—Abdominal pain—Docetaxel—melanoma	0.00345	0.00345	CcSEcCtD
Nalidixic Acid—Asthenia—Docetaxel—melanoma	0.00314	0.00314	CcSEcCtD
Nalidixic Acid—Pruritus—Docetaxel—melanoma	0.00309	0.00309	CcSEcCtD
Nalidixic Acid—Diarrhoea—Docetaxel—melanoma	0.00299	0.00299	CcSEcCtD
Nalidixic Acid—Dizziness—Docetaxel—melanoma	0.00289	0.00289	CcSEcCtD
Nalidixic Acid—Vomiting—Docetaxel—melanoma	0.00278	0.00278	CcSEcCtD
Nalidixic Acid—Rash—Docetaxel—melanoma	0.00276	0.00276	CcSEcCtD
Nalidixic Acid—Dermatitis—Docetaxel—melanoma	0.00275	0.00275	CcSEcCtD
Nalidixic Acid—Headache—Docetaxel—melanoma	0.00274	0.00274	CcSEcCtD
Nalidixic Acid—Nausea—Docetaxel—melanoma	0.0026	0.0026	CcSEcCtD
